Spectrum Pharmaceuticals Shares Outstanding 2006-2019 | SPPI

Spectrum Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Spectrum Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 103
2017 85
2016 73
2015 65
2014 65
2013 61
2012 65
2011 58
2010 50
2009 39
2008 32
2007 29
2006 24
2005 18
Spectrum Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 110
Q4 2018 103
Q3 2018 104
Q2 2018 113
Q1 2018 101
Q4 2017 85
Q3 2017 83
Q2 2017 79
Q1 2017 79
Q4 2016 73
Q3 2016 79
Q2 2016 69
Q1 2016 66
Q4 2015 65
Q3 2015 66
Q2 2015 65
Q1 2015 65
Q4 2014 65
Q3 2014 65
Q2 2014 65
Q1 2014 63
Q4 2013 61
Q3 2013 62
Q2 2013 59
Q1 2013 59
Q4 2012 65
Q3 2012 65
Q2 2012 63
Q1 2012 65
Q4 2011 58
Q3 2011 59
Q2 2011 58
Q1 2011 56
Q4 2010 50
Q3 2010 50
Q2 2010 49
Q1 2010 49
Q4 2009 39
Q3 2009 44
Q2 2009 34
Q1 2009 32
Q4 2008 32
Q3 2008 32
Q2 2008 32
Q1 2008 31
Q4 2007 29
Q3 2007 31
Q2 2007 28
Q1 2007 25
Q4 2006 24
Q3 2006 24
Q2 2006 24
Q1 2006 24
Q4 2005 18
Q3 2005 17
Q2 2005 15
Q1 2005 15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.949B $0.109B
Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.270B 34.67
Takeda Pharmaceutical (TAK) Japan $26.904B 7.90
Grifols (GRFS) Spain $13.545B 17.13
Sage Therapeutics (SAGE) United States $9.329B 0.00
Ionis Pharmaceuticals (IONS) United States $9.107B 19.91
Neurocrine Biosciences (NBIX) United States $7.829B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.485B 10.26
Catalent (CTLT) United States $7.356B 29.52
Nektar Therapeutics (NKTR) United States $6.130B 9.99
Tilray (TLRY) Canada $3.991B 0.00
FibroGen (FGEN) United States $3.795B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.537B 12.41
United Therapeutics (UTHR) United States $3.444B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.644B 398.43
PTC Therapeutics (PTCT) United States $2.497B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.091B 7.53
Xencor (XNCR) United States $1.946B 53.14
Portola Pharmaceuticals (PTLA) United States $1.915B 0.00
Tricida (TCDA) United States $1.836B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.808B 87.54
Enanta Pharmaceuticals (ENTA) United States $1.789B 24.45
Ironwood Pharmaceuticals (IRWD) United States $1.778B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Zogenix (ZGNX) United States $1.689B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.589B 0.00
Aerie Pharmaceuticals (AERI) United States $1.554B 0.00
Heron Therapeutics (HRTX) United States $1.444B 0.00
Esperion Therapeutics (ESPR) United States $1.373B 0.00
Turning Point Therapeutics (TPTX) United States $1.361B 0.00
Corcept Therapeutics (CORT) United States $1.206B 17.21
Radius Health (RDUS) United States $1.096B 0.00
ArQule (ARQL) United States $1.023B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.932B 0.00
Endo (ENDP) Ireland $0.896B 1.44
Odonate Therapeutics (ODT) United States $0.719B 0.00
Aptorum Group (APM) China $0.694B 0.00
CannTrust Holdings (CTST) Canada $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.671B 0.00
TherapeuticsMD (TXMD) United States $0.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Akebia Therapeutics (AKBA) United States $0.539B 0.00
Dermira (DERM) United States $0.537B 0.00
Translate Bio (TBIO) United States $0.519B 0.00
ChemoCentryx (CCXI) United States $0.506B 0.00
GlycoMimetics (GLYC) United States $0.503B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.452B 0.00
Flexion Therapeutics (FLXN) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 21.85
Siga Technologies (SIGA) United States $0.432B 1.02
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.391B 0.00
TCR2 Therapeutics (TCRR) United States $0.389B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.386B 0.00
Collegium Pharmaceutical (COLL) United States $0.379B 0.00
Karyopharm Therapeutics (KPTI) United States $0.360B 0.00
KalVista Pharmaceuticals (KALV) United States $0.352B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Forty Seven (FTSV) United States $0.329B 0.00
ImmunoGen (IMGN) United States $0.321B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
Harpoon Therapeutics (HARP) United States $0.295B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.286B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Xeris Pharmaceuticals (XERS) United States $0.284B 0.00
Molecular Templates (MTEM) United States $0.282B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.233B 0.00
Recro Pharma (REPH) United States $0.214B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.214B 0.00
Lannett Co Inc (LCI) United States $0.214B 2.08
Aclaris Therapeutics (ACRS) United States $0.202B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.191B 0.00
Aldeyra Therapeutics (ALDX) United States $0.188B 0.00
Calithera Biosciences (CALA) United States $0.186B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Bio Blast Pharma (ENLV) Israel $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Opexa Therapeutics (ACER) United States $0.176B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
IMV INC (IMV) Canada $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 55.44
Minerva Neurosciences (NERV) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.159B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
Redhill Biopharma (RDHL) Israel $0.154B 0.00
Majesco Entertainment (PTE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.141B 0.00
AgeX Therapeutics (AGE) United States $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Tyme Technologies (TYME) United States $0.122B 0.00
Aquestive Therapeutics (AQST) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.89
Iterum Therapeutics (ITRM) Ireland $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.092B 9.17
DURECT (DRRX) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Mast Therapeutics (SVRA) United States $0.085B 0.00
Adherex Technologies (FENC) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Otonomy (OTIC) United States $0.078B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Genocea Biosciences (GNCA) United States $0.072B 0.00
Novan (NOVN) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Neos Therapeutics (NEOS) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.051B 0.00
KemPharm (KMPH) United States $0.051B 0.00
AIT Therapeutics (AITB) Israel $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.044B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
IsoRay (ISR) United States $0.029B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.59
Pain Therapeutics (SAVA) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00